Fundraising Fox

ENB Therapeutics

New York, US · Founded 2018 · Delaware corporation · 2 known investors

enbpharma.com ↗

ENB Therapeutics develops oncology molecules that block the endothelin B receptor (ETBR) to improve immune-based cancer therapies. Its lead product, ENB-003, is used in combination with immuno-oncology agents to counter drug resistance and help the immune system target cancer cells.

BiotechHealthtech

Founders & leadership

BS
Barbara SchilbergDirector
FM
Fumitaka MoriDirector
SJ
Sumayah JamalPresident, Co-founder & Chief Scientific Officer
AS
Albert SokolExecutive Officer
SH
Sandy HarmChief Operating Officer
RS
Robert SchneiderCo-founder & Chair of Scientific Advisory Board

Investors · 2

BioAdvanceConshohocken · $500K – $1.5M
Remiges Ventures, Inc.Seattle

Reported raises · per SEC filings

Form D private placements
▶$225KraisedOct 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sumayah JamalExecutive Officer, Director
  • Barbara SchilbergDirector
  • Stuart HwangDirector
  • Walter OlesiakDirector
  • Albert SokolExecutive Officer
Offering amount
$1M
Amount sold
$225K
First sale
Sep 2023
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedJan 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barbara SchilbergDirector
  • Albert SokolExecutive Officer
  • Fumitaka MoriDirector
  • Sumayah JamalExecutive Officer, Director
Offering amount
$2.6M
Amount sold
$1.3M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.1MraisedFeb 2020 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barbara SchilbergDirector
  • Fumitaka MoriDirector
  • Sumayah JamalExecutive Officer, Director
  • Albert SokolExecutive Officer
Offering amount
$9.1M
Amount sold
$8.1M
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.